Analysis: J&J's answer to Botox may escalate war on wrinkles

[riky]

Analysis: J&J's answer to Botox may escalate war on wrinkles

<p><a href="http://news.yahoo.com/analysis-j-js-answer-botox-may-escalate-war-115831398--finance.html"><img src="http://l2.yimg.com/bt/api/res/1.2/Cg8pvLvz8922tp01EvIscQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-03-22T215846Z_1_CBRE92L1P2000_RTROPTP_2_JJ-BOTOX.JPG" width="130" height="86" alt="Howard Sobel, attending dermatologist and dermatologic surgeon at Lenox Hill Hospital in New York, demonstrates how botox or other anti-wrinkle medicines are applied via syringe to a patient at his office in New York" align="left" title="Howard Sobel, attending dermatologist and dermatologic surgeon at Lenox Hill Hospital in New York, demonstrates how botox or other anti-wrinkle medicines are applied via syringe to a patient at his office in New York" border="0" /></a>By Ransdell Pierson NEW YORK (Reuters) - Johnson &amp; Johnson may soon cause frown lines at Allergan Inc, maker of Botox. J&amp;J expects to seek U.S. approval next year for an anti-wrinkle drug that could break Botox's near monopoly, an 85 percent market share. The J&amp;J product could be available in the United States in 2015 and overseas a few years later, the company said. Two smaller drugmakers with similar products haven't made substantial inroads into the almost $900 million a year market. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login